McKesson Corporation logo
McKesson Corporation (MCK)
Compare

McKesson Corporation (MCK) Earnings Per Share (EPS): 38.47

popular:market cap|pe ratio|revenue|price history|total return

Is McKesson Corporation’s earnings per share (EPS) high or low?

McKesson Corporation's earnings per share (EPS) of 38.47 is 150% above its 5-year average of 15.41, near the high end of its 5-year range (-27.02–38.55).

As of Friday, June 19, 2026. 19.45% above its 12-month average of 32.20.

P/E Ratio|EPS CAGR|Net Income|Earnings Yield|All Metrics

MCK Earnings Per Share (EPS) Chart

MCK Earnings Per Share (EPS)
38.55+49.07% 1Y
Zoom

MCK Average Earnings Per Share (EPS) Chart

MCK Current vs Average Earnings Per Share (EPS) Chart

MCK Earnings Per Share (EPS) Metrics

EARNINGS PER SHARE (EPS)

38.47

EARNINGS PER SHARE (EPS) AVG TTM

32.20

EARNINGS PER SHARE (EPS) AVG 3Y

28.04

EARNINGS PER SHARE (EPS) AVG 5Y

15.41

EARNINGS PER SHARE (EPS) AVG 10Y

11.88

EARNINGS PER SHARE (EPS) AVG 15Y

12.38

EARNINGS PER SHARE (EPS) AVG 20Y

4.48

CURRENT VS TTM AVG

+19.45%

CURRENT VS 3Y AVG

+37.17%

CURRENT VS 5Y AVG

+149.62%

CURRENT VS 10Y AVG

+223.77%

CURRENT VS 15Y AVG

+210.81%

CURRENT VS 20Y AVG

+759.47%

MCK Competitors' Earnings Per Share (EPS)

NAMEMARKET CAPEARNINGS PER SHARE (EPS)TTM3Y5Y
McKesson Corporation (MCK)$87.88B38.4732.2028.0415.41
Elevance Health Inc. (ELV)vs ›$84.37B23.5125.4925.2324.07
HCA Healthcare, Inc. (HCA)vs ›$83.23B29.0825.4522.3920.36
Medtronic plc (MDT)vs ›$101.86B3.733.693.253.23
Cigna Corporation (CI)vs ›$73.88B23.5817.2718.4518.81
Boston Scientific Corporation (BSX)vs ›$67.32B2.381.611.190.89
Bristol-Myers Squibb Company (BMY)vs ›$110.27B3.56-0.481.470.84
Regeneron Pharmaceuticals, Inc. (REGN)vs ›$62.84B41.0441.9840.3845.10
Vertex Pharmaceuticals Incorporated (VRTX)vs ›$114.63B16.866.6910.109.99
Stryker Corporation (SYK)vs ›$118.00B8.648.187.736.75

EPS Comparison

Trailing EPS (TTM)

$38.47

Forward EPS (Est.)

$50.39

P/E Ratio

19.5

Formula: EPS = Net Income / Weighted Average Shares Outstanding

Why EPS matters:

  • Directly impacts stock valuation through P/E ratio
  • Used to calculate dividend coverage and payout ratios
  • Enables comparison across companies of different sizes
  • Growth in EPS often correlates with stock price appreciation

McKesson Corporation Earnings Per Share (EPS) Formula & Definition

EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

McKesson Corporation Earnings Per Share (EPS) FAQ

What is the earnings per share (EPS) for McKesson Corporation (MCK)?
The earnings per share (EPS) for MCK stock is 38.47.
Is McKesson Corporation's earnings per share (EPS) high or low?
McKesson Corporation's earnings per share (EPS) of 38.47 is 150% above its 5-year average of 15.41, near the high end of its 5-year range (-27.02–38.55).
What is the TTM average earnings per share (EPS) for McKesson Corporation (MCK)?
The TTM average earnings per share (EPS) for MCK stock is 32.20.
What is the 3Y average earnings per share (EPS) for McKesson Corporation (MCK)?
The 3Y average earnings per share (EPS) for MCK stock is 28.04.
What is the 5Y average earnings per share (EPS) for McKesson Corporation (MCK)?
The 5Y average earnings per share (EPS) for MCK stock is 15.41.
What is the 10Y average earnings per share (EPS) for McKesson Corporation (MCK)?
The 10Y average earnings per share (EPS) for MCK stock is 11.88.
What is the 15Y average earnings per share (EPS) for McKesson Corporation (MCK)?
The 15Y average earnings per share (EPS) for MCK stock is 12.38.
What is the 20Y average earnings per share (EPS) for McKesson Corporation (MCK)?
The 20Y average earnings per share (EPS) for MCK stock is 4.48.

McKesson Corporation Earnings Per Share (EPS) History

DATEEARNINGS PER SHARE (EPS)
2026-03-3138.55
2025-03-3125.86
2024-03-3122.54
2023-03-3125.23
2022-03-317.31
2021-03-31-27.02
2020-03-314.97
2019-03-310.17
2018-03-310.32
2017-03-3122.95
2016-03-319.82
2015-03-316.37
2014-03-315.51
2013-03-315.71
2012-03-315.70
2011-03-314.65
2010-03-314.70
2009-03-312.99
2008-03-313.40
2007-03-313.06
2006-03-312.46
2005-03-31-0.53
2004-03-312.23
2003-03-311.92
2002-03-311.47
2001-03-31-0.17
2000-03-312.57
1999-03-310.31
1998-03-311.66
1997-03-310.83

Related Metrics

P/E RatioEPS CAGRNet IncomeEarnings YieldAll Metrics

About McKesson Corporation

McKesson Corporation is a prominent global provider of healthcare services, operating extensively in both the United States and international markets. Its diverse operations are strategically organized into four key business segments. The U.S. Pharmaceutical division plays a crucial role in the distribution of a comprehensive array of pharmaceutical products, encompassing branded, generic, specialty, biosimilar, and over-the-counter medications, alongside other health-related merchandise. This segment also delivers specialized support to community-based oncology and other specialty medical practices through practice management tools, technology solutions, clinical guidance, and broader business services. Furthermore, it assists pharmacies with consulting, outsourcing, and technology services, while also furnishing financial, operational, and clinical software solutions. Internationally, the company's dedicated segment provides distribution and support services to wholesale, institutional, and retail clients across 13 European nations and Canada. The Medical-Surgical Solutions unit is focused on supplying healthcare providers with essential medical-surgical products, sophisticated logistics management, and a variety of associated services. Finally, the Prescription Technology Solutions (RxTS) segment is designed to address complex medication challenges for patients. It collaborates with biopharmaceutical companies and life sciences partners to improve patient journeys, leveraging innovative solutions for medication access and adherence by connecting pharmacies, healthcare providers, payers, and biopharma entities. This segment further offers third-party logistics and wholesale distribution assistance. Founded in 1833, McKesson Corporation maintains its corporate headquarters in Irving, Texas.

Irving, TX
44,000 employees
www.mckesson.com
Healthcare / Medical - Distribution
Sector
Healthcare
Industry
Medical - Distribution
CEO
Brian S. Tyler
View full financials